Correction: Awad et al. Repurposing Potential of the Antiparasitic Agent Ivermectin for the Treatment and/or Prophylaxis of COVID-19. Pharmaceuticals 2022, 15 , 1068.
Hoda AwadBasmala HassanSara DweekYasmeen AboelataMutasem Rawas-QalajiIman Saad AhmedPublished in: Pharmaceuticals (Basel, Switzerland) (2024)
The following paragraph, "Coinciding but insignificant findings with regards to the time to negative PCR were established by Pott-Junior et al [...].